Fundraising Fox
Delphian Therapeutics
1 known investors
Find your way into Delphian Therapeutics
Sign up to find every way you can get introduced to Delphian Therapeutics
- Your email: who you already know at Delphian Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Delphian Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.
Investors · 1
Frequently asked questions
- What does Delphian Therapeutics do?
- Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.
- Who are Delphian Therapeutics's investors?
- Delphian Therapeutics's investors include 2Flo Ventures.